These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 8294168
1. Influenza vaccination on renal transplant patients is safe and serologically effective. Grekas D, Alivanis P, Kiriazopoulou V, Dioudis C, Sioulis A, Derveniotis V, Tourkantonis A. Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):553-6. PubMed ID: 8294168 [Abstract] [Full Text] [Related]
2. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T. Scand J Urol Nephrol; 2003 Nov; 37(1):71-6. PubMed ID: 12745749 [Abstract] [Full Text] [Related]
3. Effective immunization against influenza in pediatric renal transplant recipients. Edvardsson VO, Flynn JT, Deforest A, Kaiser BA, Schulman SL, Bradley A, Palmer J, Polinsky MS, Baluarte HJ. Clin Transplant; 1996 Dec; 10(6 Pt 1):556-60. PubMed ID: 8996778 [Abstract] [Full Text] [Related]
4. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [Abstract] [Full Text] [Related]
5. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Brydak LB, Machała M, Centkowski P, Warzocha K, Biliński P. Vaccine; 2006 Nov 10; 24(44-46):6620-3. PubMed ID: 16870313 [Abstract] [Full Text] [Related]
6. Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Gaeta GB, Pariani E, Amendola A, Brancaccio G, Cuomo G, Stornaiuolo G, Zappa A, Zanetti A. Vaccine; 2009 May 26; 27(25-26):3373-5. PubMed ID: 19200844 [Abstract] [Full Text] [Related]
8. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951 [Abstract] [Full Text] [Related]
9. Occurrence and protective level of influenza infections using serology in patients with COPD in vaccination study. Kositanont U, Kanyok R, Wasi C, Wongsurakiat P, Suthamsmai T, Maranetra N. J Med Assoc Thai; 2004 Aug 27; 87(8):964-9. PubMed ID: 15471303 [Abstract] [Full Text] [Related]
10. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2007 Sep 17; 25(37-38):6692-8. PubMed ID: 17697730 [Abstract] [Full Text] [Related]
11. ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. Lindemann M, Witzke O, Lütkes P, Fiedler M, Kreuzfelder E, Philipp T, Roggendorf M, Grosse-Wilde H. Clin Immunol; 2006 Sep 17; 120(3):342-8. PubMed ID: 16631409 [Abstract] [Full Text] [Related]
12. Immune response after influenza vaccination in children with cancer. Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T. Pediatr Blood Cancer; 2005 Nov 17; 45(6):831-7. PubMed ID: 16007602 [Abstract] [Full Text] [Related]
13. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Scharpé J, Peetermans WE, Vanwalleghem J, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Evenepoel P. Am J Kidney Dis; 2009 Jul 17; 54(1):77-85. PubMed ID: 19339089 [Abstract] [Full Text] [Related]
14. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE. Vaccine; 2008 Sep 08; 26(38):4940-6. PubMed ID: 18662737 [Abstract] [Full Text] [Related]
15. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. Jo YM, Song JY, Hwang IS, Lee J, Oh SC, Kim JS, Kim SR, Kim WJ, Cheong HJ. J Med Virol; 2009 Apr 08; 81(4):722-7. PubMed ID: 19235853 [Abstract] [Full Text] [Related]
16. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients. Wallin L, Quintilio W, Locatelli F, Cassel A, Silva MB, Skare TL. Acta Reumatol Port; 2009 Apr 08; 34(3):498-502. PubMed ID: 19820674 [Abstract] [Full Text] [Related]
17. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine]. Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH. Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 08; 24(7):570-3. PubMed ID: 12975010 [Abstract] [Full Text] [Related]
18. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Chiu SS, Peiris JS, Chan KH, Wong WH, Lau YL. Pediatrics; 2007 Jun 08; 119(6):1076-82. PubMed ID: 17545373 [Abstract] [Full Text] [Related]
19. [Simultaneous vaccination against influenza and invasive pneumococcal disease in chronic dialysis patients]. Trmal J, Havlícková M, Bícová R, Bitterová Z, Kelerová J. Epidemiol Mikrobiol Imunol; 2005 Aug 08; 54(3):123-8. PubMed ID: 16173523 [Abstract] [Full Text] [Related]
20. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J. J Med Virol; 2007 Mar 08; 79(3):320-5. PubMed ID: 17245715 [Abstract] [Full Text] [Related] Page: [Next] [New Search]